메뉴 건너뛰기




Volumn 57, Issue 1, 2011, Pages 7-8

Determining the optimal approach for government-regulated genetic testing

Author keywords

[No Author keywords available]

Indexed keywords

CYSTIC FIBROSIS; FOOD AND DRUG ADMINISTRATION; GENETIC SCREENING; GENETICS; GENOMICS; GOVERNMENT; HEALTH CARE PERSONNEL; MARFAN SYNDROME; REVIEW; UNITED STATES;

EID: 78650968364     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2010.156687     Document Type: Review
Times cited : (1)

References (7)
  • 1
    • 78650987519 scopus 로고    scopus 로고
    • FDA. Letter to Pathway Genomics Corporation concerning the Pathway Genomics genetic health report. (Accessed September
    • FDA. Letter to Pathway Genomics Corporation concerning the Pathway Genomics genetic health report. http://www. fda.gov/MedicalDevices/Resources forYou/Industry/ucm211866.htm (Accessed September 2010).
    • (2010)
  • 2
    • 78650968405 scopus 로고    scopus 로고
    • FDA FDA/CDRH public meeting: Oversight of laboratory developed tests (LDTs), date July 19-20, (Accessed September 2010)
    • FDA. FDA/CDRH public meeting: Oversight of laboratory developed tests (LDTs), date July 19-20, 2010. http://www.fda.gov/MedicalDevices/NewsEvents/ WorkshopsConferences/ucm212830.htm (Accessed September 2010).
    • (2010)
  • 3
    • 78650991368 scopus 로고    scopus 로고
    • U.S. House of Representatives Committee on Energy and Commerce. Hearing on "Direct-To- Consumer Genetic Testing and the Consequences to the Public Health." (Accessed September
    • U.S. House of Representatives Committee on Energy and Commerce. Hearing on "Direct-To- Consumer Genetic Testing and the Consequences to the Public Health."http://energycommerce.house.gov/index.php?option-com- content&view-article&id-2083:hearing-on-direct-to-consumergenetic- testing-and-the-consequences-to-the-publichealth&catid-133: subcommittee-on-oversight-andinvestigations&Itemid-73 (Accessed September 2010).
    • (2010)
  • 4
    • 78650986571 scopus 로고    scopus 로고
    • U.S. GAO. Direct-to-consumer genetic tests: Misleading test results are further complicated by deceptive marketing and other questionable practices. Accessed September
    • U.S. GAO. Direct-to-consumer genetic tests: Misleading test results are further complicated by deceptive marketing and other questionable practices. http://www.gao.gov/products/GAO-10-847T (Accessed September 2010).
    • (2010)
  • 5
    • 77955619710 scopus 로고    scopus 로고
    • Which way for genetic-test regulation? Leave test interpretation to specialists
    • Beaudet AL. Which way for genetic-test regulation? Leave test interpretation to specialists. Nature 2010;466:816-7.
    • (2010) Nature , Issue.466 , pp. 816-7
    • Beaudet, A.L.1
  • 6
    • 77955626179 scopus 로고    scopus 로고
    • Which way for genetic-test regulation? Assign regulation appropriate to the level of risk
    • Javitt G. Which way for genetic-test regulation? Assign regulation appropriate to the level of risk. Nature 2010;466:817-8.
    • (2010) Nature , Issue.466 , pp. 817-8
    • Javitt, G.1
  • 7
    • 77955630483 scopus 로고    scopus 로고
    • U.S. system of oversight of genetic testing: A response to the charge of the Secretary of Health and Human Services. Accessed September
    • The Secretary's Advisory Committee on Genetics, Health, and Society. U.S. system of oversight of genetic testing: A response to the charge of the Secretary of Health and Human Services. http://oba.od.nih.gov/oba/SACGHS/ reports/SACGHS-oversight-report.pdf (Accessed September 2010).
    • (2010) The Secretary's Advisory Committee on Genetics, Health, and Society


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.